Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Canadian Medical Association Journal
|
August 15, 1984
Invasive aspergillosis in a "healthy" patient
K J Ascah, R H Hyland, M A Hutcheon, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1997
Analysis of FcgammaRII gene polymorphisms in Wegener's granulomatosis
J C Edberg, E Wainstein, J Wu, et al.
Scandinavian Journal of Rheumatology
|
May 30, 2020
Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis
P Emery, C-H Suh, M E Weinblatt, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
D E Furst, E C Keystone, F C Breedveld, et al.
Nature Medicine
|
May 1, 1995
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis
S Albani, E C Keystone, J L Nelson, et al.
The Journal of Rheumatology
|
September 17, 2013
Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort
Jamie A Harris, Vivian P Bykerk, Carol A Hitchon, et al.
The Journal of Clinical Investigation
|
August 1, 1997
Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis
A La Cava, J L Nelson, W E Ollier, et al.
Annals of the Rheumatic Diseases
|
October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
D E Furst, F C Breedveld, J R Kalden, et al.
ACR Open Rheumatology
|
December 25, 2019
Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort
L Ellingwood, O Schieir, M F Valois, et al.
Arthritis Care & Research
|
May 20, 2015
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients
J R Curtis, S Yang, L Chen, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Canadian Medical Association Journal
|
August 15, 1984
Invasive aspergillosis in a "healthy" patient
K J Ascah, R H Hyland, M A Hutcheon, et al.
Experimental and Clinical Immunogenetics
|
January 1, 1997
Analysis of FcgammaRII gene polymorphisms in Wegener's granulomatosis
J C Edberg, E Wainstein, J Wu, et al.
Scandinavian Journal of Rheumatology
|
May 30, 2020
Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis
P Emery, C-H Suh, M E Weinblatt, et al.
Annals of the Rheumatic Diseases
|
March 14, 2002
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001)
D E Furst, E C Keystone, F C Breedveld, et al.
Nature Medicine
|
May 1, 1995
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis
S Albani, E C Keystone, J L Nelson, et al.
The Journal of Rheumatology
|
September 17, 2013
Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort
Jamie A Harris, Vivian P Bykerk, Carol A Hitchon, et al.
The Journal of Clinical Investigation
|
August 1, 1997
Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis
A La Cava, J L Nelson, W E Ollier, et al.
Annals of the Rheumatic Diseases
|
October 14, 2004
Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
D E Furst, F C Breedveld, J R Kalden, et al.
ACR Open Rheumatology
|
December 25, 2019
Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort
L Ellingwood, O Schieir, M F Valois, et al.
Arthritis Care & Research
|
May 20, 2015
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients
J R Curtis, S Yang, L Chen, et al.
Page
of 13